Skip Nav Destination
A phase 1/2 ascending dose study and open-label extension study of voxelotor in patients with sickle cell disease
The response to lymphodepletion impacts PFS in patients with aggressive non-Hodgkin lymphoma treated with CD19 CAR T cells
Issue Archive
Table of Contents
Editorial
Blood Commentaries
Plenary Paper
Transfusion Medicine
Clinical Trials and Observations
A phase 1/2 ascending dose study and open-label extension study of voxelotor in patients with sickle cell disease
Clinical Trials & Observations
Jo Howard,Claire Jane Hemmaway,Paul Telfer,D. Mark Layton,John Porter,Moji Awogbade,Timothy Mant,Daniel D. Gretler,Kobina Dufu,Athiwat Hutchaleelaha,Mira Patel,Vincent Siu,Sandra Dixon,Noel Landsman,Margaret Tonda,Joshua Lehrer-Graiwer
There is a Blood Commentary on this article in this issue.
Immunobiology and Immunotherapy
The response to lymphodepletion impacts PFS in patients with aggressive non-Hodgkin lymphoma treated with CD19 CAR T cells
Clinical Trials & Observations
Alexandre V. Hirayama,Jordan Gauthier,Kevin A. Hay,Jenna M. Voutsinas,Qian Wu,Ted Gooley,Daniel Li,Sindhu Cherian,Xueyan Chen,Barbara S. Pender,Reed M. Hawkins,Aesha Vakil,Rachel N. Steinmetz,Utkarsh H. Acharya,Ryan D. Cassaday,Aude G. Chapuis,Tejaswini M. Dhawale,Paul C. Hendrie,Hans-Peter Kiem,Ryan C. Lynch,Jorge Ramos,Mazyar Shadman,Brian G. Till,Stanley R. Riddell,David G. Maloney,Cameron J. Turtle
Red Cells, Iron, and Erythropoiesis
A gene-based recessive diplotype exome scan discovers FGF6, a novel hepcidin-regulating iron-metabolism gene
Shicheng Guo,Shuai Jiang,Narendranath Epperla,Yanyun Ma,Mehdi Maadooliat,Zhan Ye,Brent Olson,Minghua Wang,Terrie Kitchner,Jeffrey Joyce,Peng An,Fudi Wang,Robert Strenn,Joseph J. Mazza,Jennifer K. Meece,Wenyu Wu,Li Jin,Judith A. Smith,Jiucun Wang,Steven J. Schrodi
Thrombosis and Hemostasis
Blood Work
-
Cover Image
Cover Image
- PDF Icon Editorial BoardEditorial Board
Advertisement intended for health care professionals
Email alerts
Advertisement intended for health care professionals





